Cargando…

Systemic Bevacizumab for Severe Recurrent Respiratory Papillomatosis

Recurrent respiratory papillomatosis (RRP) is the most common benign pediatric laryngeal neoplasm. Various adjuvant medical therapies have failed to reliably decrease surgical frequency in this challenging airway disease. Recently, systemic bevacizumab has shown promise in advanced, treatment-resist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tatineni, Swetha, Warren, Zachary, Applebaum, Mark A., Baroody, Fuad M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726241/ https://www.ncbi.nlm.nih.gov/pubmed/36483909 http://dx.doi.org/10.1155/2022/2767996

Ejemplares similares

Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis
por: MOHR, MICHAEL, et al.
Publicado: (2014)

A case report describing the use of systemic bevacizumab in the treatment of recurrent respiratory papillomatosis with pulmonary involvement
por: O'Brien, Amy, et al.
Publicado: (2023)

Recurrent respiratory papillomatosis with lung involvement
por: Molodtsova, Valentina, et al.
Publicado: (2018)

Recurrent respiratory papillomatosis: the role of cidofovir
por: Tran, Mai Ngoc, et al.
Publicado: (2018)

Systemic and Intralesional Bevacizumab in Juvenile Onset Recurrent Respiratory Papillomatosis: A Report of Two Cases
por: Goyal, Arun, et al.
Publicado: (2021)

Recurrent Respiratory Papillomatosis (RRP)—Juvenile Onset
por: Dyrstad, Sara W., et al.
Publicado: (2008)

Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review
por: Pogoda, Louis, et al.
Publicado: (2022)

Otolaryngology Away Subinternships: An Analysis of the Application Process and Survey of Current Applicants' Perspectives
por: Cyberski, Thomas, et al.
Publicado: (2023)

Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Scoping Review from 2009 to 2022
por: Torres-Canchala, Laura, et al.
Publicado: (2022)

Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?
por: Derkay, Craig S., et al.
Publicado: (2022)

Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two Cases
por: Bedoya, Armando, et al.
Publicado: (2017)

Pegylated interferon for treating severe recurrent respiratory papillomatosis in a child: case report
por: Maunsell, Rebecca, et al.
Publicado: (2017)

Epidermal growth factor receptor inhibitor therapy for recurrent respiratory papillomatosis
por: Moldan, Matthew M., et al.
Publicado: (2013)

Risk factors associated with severe recurrent respiratory papillomatosis
por: Khan, Muddaseer, et al.
Publicado: (2019)

Recurrent respiratory papillomatosis with lower airway involvement in a young woman
por: Mamaeva, Tatiana, et al.
Publicado: (2020)

Systemic bevacizumab for pediatric patients with aggressive recurrent respiratory papillomatosis: One single‐center experience of eight patients
por: Liu, Zengjun, et al.
Publicado: (2023)

Juvenile-onset recurrent respiratory papillomatosis with pulmonary involvement and carcinomatous transformation
por: Mitsumoto, Gabriel Lorente, et al.
Publicado: (2018)

Recurrent respiratory papillomatosis: current and future perspectives
por: Carifi, Marco, et al.
Publicado: (2015)

Current and future management of recurrent respiratory papillomatosis
por: Ivancic, Ryan, et al.
Publicado: (2018)

Recurrent respiratory papillomatosis: A 2020 perspective
por: Benedict, Jacob J., et al.
Publicado: (2021)

Efficacy of cidofovir in recurrent juvenile respiratory papillomatosis
por: Valera, Fabiana, et al.
Publicado: (2015)

Associations of FoxP3 gene polymorphisms with severe recurrent respiratory papillomatosis in Korean patients
por: Kwon, Tack-Kyun, et al.
Publicado: (2017)

Successful Treatment of Adult-Onset Recurrent Respiratory Papillomatosis with CO(2) Laser and Photodynamic Therapy
por: Lu, Sheng, et al.
Publicado: (2019)

Association between human papillomavirus particle production and the severity of recurrent respiratory papillomatosis
por: Yamada, Satoshi, et al.
Publicado: (2023)

Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis
por: Broekema, Ferdinand I., et al.
Publicado: (2008)

Recurrent respiratory papillomatosis: an overview of current thinking and treatment
por: Goon, Peter, et al.
Publicado: (2007)

Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis
por: Wierzbicka, Małgorzata, et al.
Publicado: (2011)

Recurrent respiratory papillomatosis (RRP)–time for a reckoning?
por: Kin Cho Goon, Peter, et al.
Publicado: (2017)

Laryngotracheobronchial papillomatosis: an uncommon cause of recurrent respiratory infection
por: Ribeiro, Bruno Niemeyer de Freitas, et al.
Publicado: (2020)

HPV and Recurrent Respiratory Papillomatosis: A Brief Review
por: Ouda, Amr Mohamed, et al.
Publicado: (2021)

Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis
por: Avelino, Melissa Ameloti Gomes, et al.
Publicado: (2015)

Recurrent laryngeal inflammatory myofibroblastic tumor with positive anaplastic lymphoma kinase mimicking recurrent respiratory papillomatosis: a case report
por: He, Chun-yan, et al.
Publicado: (2014)

Recurrent respiratory papillomatosis (RRP) of tracheobronchial tree presenting as lung collapse with malignant transformation after a decade
por: Ling, Sai-on, et al.
Publicado: (2023)

Risk Factors for Aggressive Recurrent Respiratory Papillomatosis in Adults and Juveniles
por: Omland, Turid, et al.
Publicado: (2014)

Quality and readability assessment of websites related to recurrent respiratory papillomatosis
por: San Giorgi, Michel R.M., et al.
Publicado: (2017)

Hemoptysis in recurrent respiratory papillomatosis: also think about aspergillosis
por: Dalpiaz, Giorgia, et al.
Publicado: (2018)

An updated review of the epidemiological factors associated with recurrent respiratory papillomatosis
por: Welschmeyer, Alexandra, et al.
Publicado: (2021)

Estimated incidence of juvenile-onset recurrent respiratory papillomatosis in Korea
por: Oh, Jin-Kyoung, et al.
Publicado: (2021)

Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir
por: FUSCONI, M., et al.
Publicado: (2014)

Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis
por: Tjon Pian Gi, Robin E. A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4kkfldipq9b1942m17tf5mh9l4